"","V1","V2","V3","V4","V5","V6","V7","V8","V9","V10","V11","V12","V13","V14","V15","V16","V17","V18","V19","V20","V21","V22","V23","V24","V25","V26","V27","V28","V29","V30","V31","V32","V33","V34","V35","V36","V37","V38","V39","V40","V41","V42","V43","V44","V45","V46","V47","V48","V49","V50","V51","V52","V53","V54","V55","V56","V57","V58","V59","V60","V61","V62","V63","V64","V65","V66","V67","V68","V69","V70","V71","V72","V73","V74","V75","V76","V77","V78","V79","V80","V81","V82","V83","V84","V85","V86","V87","V88","V89","V90","V91","V92","V93","V94","V95","V96","V97","V98","V99","V100","V101","V102","V103","V104","V105","V106","V107","V108","V109","V110","V111","V112","V113","V114","V115","V116","V117","V118","V119","V120","V121","V122","V123","V124","V125","V126","V127","V128","V129","V130","V131","V132","V133","V134","V135","V136","V137","V138","V139","V140","V141","V142","V143","V144","V145","V146","V147","V148","V149","V150","V151","V152","V153","V154","V155","V156","V157","V158","V159","V160","V161","V162","V163","V164","V165","V166","V167","V168","V169","V170","V171","V172","V173","V174","V175","V176","V177","V178","V179","V180","V181","V182","V183","V184","V185","V186","V187","V188","V189","V190"
"1","abs382.txt","background","","the","purpose","of","current","study","was","to","determine","quality","life","andtumor","control","from","a","prospective","phase","2","clinical","trial","evaluating","deintensifiedchemoradiotherapy","for","favorable","risk","human","papillomavirus","(hpv)-associatedoropharyngeal","squamous","cell","carcinoma","methods","patients","with","t0-t3","n0-n2c","m0","p16-positive","disease","and","minimalsmoking","history","were","treated","60","grays","intensity-modulated","radiotherapywith","concurrent","weekly","intravenous","cisplatin","(30","mg/m2",")","primary","studyendpoint","pathologic","complete","response","rate","based","on","biopsy","primarysite","dissection","pretreatment","positive","lymph","node","regions","pathologiccomplete","as","previously","reported","86%","herein","authors","reportsecondary","endpoint","measures","local","regional","cause-specificsurvival","distant","metastasis-free","survival","overall","andpatient-reported","outcomes","(european","organization","research","treatment","ofcancer","[eortc]","questionnaire","[eortc","qlq-c30]","thepatient-reported","version","common","terminology","criteria","adverseevents","[pro-ctcae])","results","total","44","enrolled","median","follow-up","36","months(88%","≥2","years)","3-year","rates","100%","95%","respectively","mean","before","after","eortcqol","scores","global","80","78","swallowing","11","dry","mouth","16","41","andsticky","saliva","6","29","pro-ctcae","0","4","7","1","approximately","39%","patientsrequired","feeding","tube","(median","duration","15","weeks","none","permanent)","therewere","no","≥grade","3","late","adverse","events","conclusions","favorable-risk","papillomavirus-associatedoropharyngeal","substantially","decreased","intensity","oftherapy","radiotherapy","low-dosecisplatin","produced","better","preservation","compared","standardtherapies","while","maintaining","excellent","tumor","cancer2018","124","2347-54","©","2018","american","cancer","society"
